Trial Profile
Minimizing post-procedural vascular complications: comparing bivalirudin versus heparin/GP [glycoprotein] IIB/IIA in patients undergoing percutaneous coronary intervention
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Bivalirudin (Primary) ; Eptifibatide; GPIIb-IIIa antagonists; Heparin
- Indications Coronary disorders; Thrombosis
- Focus Adverse reactions; Therapeutic Use